The Gutkind laboratory demonstrated that SEMA4D, cleaved from head and neck squamous cell carcinoma cells (HNSCC), enhances endothelial cell migration by binding to Plexin B1 receptors expressed on these cells [48]. This evidence concerns the gene SEMA4D and head and neck squamous cell carcinoma.